LamB protein is involved in the transport of maltose across the outer membrane and constitutes the receptor for phage X. In this study we characterized six previously described anti-LamB monoclonal antibodies (mAbs). Four of these, the E-mAbs, recognized determinants that were exposed at the cell surface, whereas the other two, the I-mAbs, recognized determinants which were not exposed. Competition experiments demonstrated that the domains recognized by these two classes of mAbs were completely distinct. In addition, the E-mAbs prevented LamB from neutralizing phage A in vitro and protected LamB against proteolytic degradation, whereas the I-mAbs had no such effects. The E-mAbs have been shown previously to constitute two classes; some E-mAbs inhibit maltose transport in vivo, and others do not. Immunoelectron microscopy demonstrated that the I-mAbs also define at least two types of determinants. One of these, which is accessible in membrane fragments from a mutant (lpp) devoid of lipoprotein but not in membrane fragments from an lpp+ strain, probably corresponds to a region of LamB that is involved in the interactions with peptidoglycan. The other determinant, which is fully accessible in LamBpeptidoglycan complexes and in LamB-containing phospholipid vesicles but only slightly accessible in membrane fragments from an lpp mutant, is probably located very close to the inner surface of the outer membrane. LamB also contains at least one additional determinant, which (i) is exposed at the inner surface of the membrane, (ii) is accessible to antibodies in membrane fragments from an lpp+ strain, and (iii) may be involved in the interaction of LamB with the periplasmic maltose-binding protein.
LamB protein is one of the major cellular proteins (approximately 105 copies per cell) when Escherichia coli is grown in the presence of maltose (2, 24) . The primary function of this protein is to permit the diffusion of maltose and maltodextrins across the outer membrane (2, 17, 30) . In detergent solutions (14, 20) and probably in membranes (19, 23) , LamB is a trimer composed of three identical subunits containing 421 amino acids (5) . The amino acid sequence of LamB was deduced from the nucleotide sequence of its structural gene (5) , whereas circular dichroism studies (14) indicated a predominance of p-sheets in its secondary structure.
Like other pore-forming proteins (22, 26) , LamB is believed to span the entire outer membrane. At the outer face of the membrane LamB acts as a receptor for phages, such as X (24) and K10 (25) , is recognized by specific antibodies (8) , and binds maltose and maltodextrins (6) . Evidence that LamB is exposed on the inner face of the outer membrane is more circumstantial. Genetic (11, 31) and biochemical (1, 18) experiments have indicated that this protein interacts with the periplasmic maltose-binding protein, and this feature has been included in models describing the mechanism of maltose transport (11, 28) . The interaction with peptidoglycan also suggests that LamB may be exposed on the inner face of the outer membrane. LamB remains associated with the peptidoglycan sacculus when cells are dissolved in sodium dodecyl sulfate at 60°C in the presence of Mg2+ ions (9) ; it can be eluted from the sacculus by removing the Mg2" ions or by increasing the salt concentration and can be reassociated with the sacculus under adequate conditions (32) . However, reassociation requires the presence of lipoprotein, which is covalently bound to peptidoglycan and which is believed to be at least partially embedded in the outer membrane (3, 22, 32) . Therefore, the association of LamB with the sacculus could result from LamB-lipoprotein interactions that occur within the outer membrane and does not necessarily imply that LamB protrudes at the inner face of this membrane.
To examine how LamB is inserted in the membrane, we used monoclonal antibodies (mAbs) directed against the protein, as recently described by Gabay and Schwartz (8) . Some of these mAbs were shown previously to recognize determinants that were exposed at the bacterial surface; they inhibited the adsorption of X and K10, and some also inhibited maltose transport. The other mAbs did not bind to intact cells; one bound to LamB-peptidoglycan complexes, and because of this it was proposed that the antigenic site recognized by this mAb is located within the membrane. In other cases the mAbs which did not bind to the surfaces of intact cells only recognized solubilized LamB that was obtained after elution from the peptidoglycan by extraction with detergent and EDTA; it was assumed that these mAbs recognized sites involve in the LamB-peptidoglycan interaction (8) .
In this paper we further characterize the sites recognized by the different classes of mAbs and provide more direct evidence that LamB is accessible at the periplasmic face of the outer membrane.
MATERIALS AND METHODS
Bacterial strains and medium. Strain popll30 (ompR his) was used for LamB purification (9) . The following other strains were also used in this work: pop3 (araD139 AlacU169 rpsL relA thi; strain MC4100 of Casadaban [4] ); pop3205, a derivative of pop3 carrying the nonsense mutation IamB102 (12); JE5506 (pps his proA argE thi lac xyl mtl tsx); and JE5505, an Ipp mutant of strain JE5506 (29) . These bacteria were grown in M63 medium (24) supplemented with 0.4% maltose and the necessary amino acids and vitamins.
Purification of LamB. LamB-peptidoglycan complexes were obtained as described by Gabay and Yasunaka (9) . These complexes were dissociated in 10 mM Tris-hydrochloride (pH 7.4) containing 5 mM EDTA and 2% octylpolyoxyethylene (octyl-POE) a gift from J. P. Rosenbusch (26) . After 1 h of centrifugation at 100,000 x g, the supernatant was adjusted to 20 mM MgCl2, phenylmethylsulfonyl fluoride-treated DNase I (0.01 mg/ml; Sigma Chemical Co.) was added, and the mixture was incubated for 1 h at 37°C. During this step, DNA hydrolysis led to a reduction in the viscosity of the preparation, and the addition of Mg2+ ions induced precipitation of the LamB protein. After additional centrifugation at 100,000 x g for 1 h, the resulting pellet was suspended in 10 mM Tris-hydrochloride (pH 7.4)-S5 mM EDTA-2% octyl-POE and incubated for 1 h at 37°C. The insoluble material was removed by centrifugation at 100,000 x g for 1 h, and the supernatant was loaded onto a column containing mAb3O2 coupled (13) (20) .
Radioactively labeled LamB was prepared as described above, after the bacteria were grown in a lowsulfur medium containing 0.1 mCi of 35S (25 to 40 Ci/ ml; Amersham France) per ml (8) . More coli membrane fragments were obtained from maltosegrown cells. The procedure used was essentially that of Osborn et al. (21) and involved treatment of cells with lysozyme and EDTA to produce spheroplasts, sonication to fragment spheroplasts, and ultracentrifugation. No attempt was made to separate outer and inner membranes. Each preparation contained a mixture of large and small fragments. Since only the former could be labeled with anti-LamB antibodies (see below), they were believed to correspond to outer membrane fragments.
LamB-containing reconstituted vesicles were prepared by the dialysis method (26) . Briefly, 1 ml of LamB dissolved in 1 ml of a solution containing 3% octyl-POE, 0.1 M NaCl, 1 mM MgCl2, 0.02% NaN3, and 10 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) (pH 7.4) was transferred to a tube that was internally coated with a dried film of soybean phosphatidylcholine (type III; Sigma). The resulting suspension was vigorously mixed with a Vortex mixer for S min and dialyzed first for 16 h and then twice for 4 h against 300 ml of the same buffer without detergent.
Both types of vesicles were diluted 1:10 in phosphate-buffered saline (PBS) and adsorbed onto glowdischarged Formvar-coated carbon grids for 1 min at room temperature. The grids were rinsed extensively with PBS containing 0.5% bovine serum albumin (M buffer) and then incubated for 1 h in a solution of antibody diluted in M buffer. The grids were then washed once more with M buffer and floated for 1 h at room temperature over a solution of a protein A-gold complex (10). The grids were washed again with M buffer and then with PBS, floated for 30 s over doubledistilled water, and stained with a 2% sodium phosphotungstate solution at pH 7.0. Micrographs were obtained with a Siemens model 101 electron microscope.
RESULTS
Affinity of the mAbs for LamB. Gabay and Schwartz distinguished four classes of mAbs directed against LamB. The mAbs which recognize determinants exposed at the cell surface (mAbs 302, 177, 347, and 72) are referred to collectively as E-mAbs. The other mAbs, which are believed to recognize internal determinants, are referred to as I-mAbs. An estimate of the affinity of the mAbs for LamB protein was obtained by using radioactive LamB protein and precipitating the immune complexes with S. aureus cells. With the four mAbs tested we obtained linear Scatchard plots from which apparent Kd values were calculated by using 141,000 as the molecular weight of the LamB trimer. The apparent Kd values were 0.27, 0.24, 1.1, and 1.4 nM for mAbs 302, 347, 436, and 141, respectively (Fig. 1) . With such high affinities the interactions between LamB and the mAbs could be considered essentially irreversible. This greatly facilitated the design of the competition experiments described below.
Competition between Fab fragments and antibodies. The possible overlapping of the binding sites for the different mAbs were determined in competition studies. We used the fact that all of the available anti-LamB mAbs are recognized by protein A (8) . Fab fragments, which are not recognized by protein A, were used as competitors in immunoprecipitation experiments with intact antibodies and S. aureus cells. The results obtained with the Fab fragments from one EmAb (E-mAb 302) and one I-mAb (1-mAb 436) are shown in Fig. 2 . An excess of E-mAb 302 Fab inhibited the immunoprecipitation observed in the presence of the E-mAbs, but had no effect on the immunoprecipitation induced by the ImAbs. Conversely, the I-mAb 436 Fab fragment inhibited the immunoprecipitation observed in the presence of mAbs 436 and 141, but had little or no effect in the presence of the E-mAbs. This result indicates that the domain recognized by ImAbs 141 and 436 is completely distinct from the domain recognized by the E-mAbs.
Additional information was obtained by performing competition experiments involving two preparations of polyclonal anti-LamB antiserum. One preparation (tS) had been preadsorbed with cells devoid of LamB protein and therefore probably contained antibodies that recognized all domains of LamB. The other preparation (aS) had been preadsorbed with lamB+ cells and was thereby depleted of the antibodies which recog- nized determinants located at the cell surface. The Fab fragment from mAb 302 failed to compete with aS. This was predictable since mAb 302 recognized an external determinant, whereas aS was specific for internal determinants. However the mAb 302 Fab fragment was also very inefficient in competing with tS. This indicates that LamB has E determinants which do not overlap with the determinant recognized by mAb 302 and are therefore different from the determinants recognized by the four available EmAbs. Similarly, the incomplete competition between mAb 436 and aS indicates that LamB has I determinants which do not overlap with the determinant recognized by mAb 436.
Effect of the mAbs on the interaction between LamB and phage X. The E-mAbs were shown previously to prevent the adsorption of phage A in vivo. Therefore, it was not surprising to find that mAbs 302 and 347 prevented LamB from inactivating XVho in vitro (Fig. 3) . In contrast, the two 1-mAbs failed to prevent LamB from inactivating AVho in vitro; this result was less predictable. Indeed, although these two mAbs had no effect on X adsorption in vivo, this was an obvious consequence of their inability to react with the cell surface. In vitro, where they could interact with LamB, they could have altered the conformation of this protein in such a way that it would have lost its ability to inactivate the phage.
Proteolytic digestion of LamB: effect of the mAbs. Like the other pore-forming proteins of E. coli, LamB is extremely resistant to proteolysis (22) . However, we found that by using high concentrations of subtilisin (ratio of enzyme to LamB, 1:2) and long incubation times (48 h at 37°C) it was possible to obtain essentially complete inactivation of LamB, as assayed by XVho neutralization, and conversion of LamB to smaller peptides. The major hydrolysis product was a 22,000-dalton peptide, but 14,000-and 34,000-dalton peptides were also detected. When incubated under the same conditions but in the absence of subtilisin, LamB remained fully active.
To study the effect of the mAbs on this proteolytic reaction, we used a somewhat shorter incubation time (24 h). Under these conditions approximately 80% of LamB was converted to smaller peptides (Fig. 4) . Preincubation of LamB with I-mAb 436 or 141 had no effect on this reaction. On the other hand, the EmAbs protected LamB against proteolytic degradation. Results identical to those shown in Fig. 4 were obtained when we used 100-foldhigher concentrations of mAbs or Fab fragments. When the gel shown in Fig. 4 22 ,000-to 26,000-dalton peptides similar to the Fab and Fc fragments (data not shown).
All of the experiments described above reinforce the notion that the E-mAbs recognize a domain of the LamB protein which is different from the domain recognized by the 1-mAbs. The domain recognized by the E-mAbs is clearly located at the cell surface. The experiments described below provided information regarding the locations of the sites recognized by the ImAbs.
Locations of the antigenic determinants when LamB is inserted in a membrane. The E-mAB determinants were known to be accessible when LamB was inserted in the bacterial outer membrane, but very little was known about the accessibility of the sites recognized by the ImAbs or even about the existence of these sites in the absence of detergent. A first set of experiments was performed after LamB was inserted in artificial phosphatidylcholine vesicles. Attempts to evaluate the accessibility of the antigenic sites by immunoprecipitation were unsuccessful due to the retention of the vesicles by the immunoadsorbent. Instead, we developed a rap id immunoelectron microscopy technique in which the vesicles were preadsorbed to the grids before reaction with the antibodies. As Fig. 5 shows, two kinds of vesicles were identified. One population was composed of small clear vesicles which were not labeled, and the other population was composed of large isolated vesicles, which were labeled by all of the anti-LamB mAbs, including 1-mAbs 436 and 141, but not by the IDA 7 control immunoglobulin.
The same type of experiment was then performed with natural membrane fragments that were obtained after sonication of bacterial spheroplasts. These fragments were labeled by E-mAb 302 (Fig. 6a) , showing that the external face of the outer membrane was exposed in these fragments. However, two lines of evidence indicated that these membranes were also accessible from the periplasmic face. First, OmpA, an outer membrane protein which has a protease-sensitive site at the inner face of the membrane (22) , could be cleaved by trypsin (data not shown). Second, the aS serum which did not recognize external determinants of LamB did interact with these fragments (Fig.  6b ).
Although the results described above indicated that the periplasmic face of the membrane was accessible in the outer membrane fragments and even that some LamB determinants were exposed on this face, no labeling was obtained with mAbs 436 and 141 ( Fig. 6c and d) . This result was somewhat surprising since the determinants recognized by these mAbs had been shown to be accessible in artificial vesicles (Fig. presence in the latter of lipoprotein, which an-5).
chors the outer membrane to the peptidoglycan One major difference between the artificial sacculus (22) . To test whether the lack of reacmembrane and the E. coli outer membrane is the tivity of mAbs 436 and 141 with the outer The grids were washed, treated with gold-labeled protein A, washed, and negatively stained. Results identical to those shown were obtained by using vesicles from strain JE5506, which is the lpp+ parent of strain JE5505. (Fig. 7d) .
DISCUSSION
The properties of the six mAbs which we studied are summarized in Table 1 . These properties allow us to define the following two distinct, nonoverlapping domains in the LamB protein: the E domain, which is exposed at the cell surface, and the I domain, which is not.
The E domain was previously shown to contain at least two antigenic sites, one defined by mAbs 347 and 72, which inhibit maltose transport in intact bacteria, and the other defined by mAbs 302 and 177, which do not (8) . In this paper we show that these two determinants must overlap or at least be very close to one another. Indeed, the Fab fragment from mAb 302 inhibited the binding of the three other E-mAbs. In addition, the four E-mAbs had identical effects on the X phage-neutralizing activity of LamB in vitro and on LamB proteolysis. The simplest interpretation of these results is that the sites recognized by the four E-mAbs share a region which (i) is exposed at the bacterial surface in vivo, (ii) is involved in the interaction of LamB with phage X, and (iii) contains the primary target for proteolytic attack of LamB in vitro. (21) , they would have been expected to prevent trypsin from attacking the carboxyl end of the OmpA protein (22) and to prevent aS from interacting with the membrane fragments. This was not the case.
The site recognized by mAb 141 is clearly not involved in the interaction of LamB with peptidoglycan since it is accessible in LamB-peptidoglycan complexes. Gabay and Schwartz (8) have suggested that this site could be buried within the membrane. However, since (i) this site is fully accessible when LamB is inserted in phospholipid vesicles and (ii) it overlaps the site of mAb 436, which is fully accessible in the same membrane fragments it seems that the mAb 141 site is not deeply embedded in the lipid bilayer; rather, it may be mostly located on the periplasmic face of the outer membrane.
The existence of at least one additional antigenic site in the I domain is suggested by the fact that unlike mAbs 141 and 436, the LamB-specific serum which has been preadsorbed with lamB+ cells, can react with outer membrane vesicles from a wild-type strain. The fact that aS reacts with outer membrane vesicles of lpp+ bacteria indicates that a region of LamB must be accessible at the periplasmic face of the outer membrane, even in the presence of lipoprotein. Part or all of this region could be the region which interacts with the periplasmic maltosebinding protein (1) . Figure 8 shows our present view of the location of the antigenic sites studied in this work with respect to the outer membrane and to functional sites on the LamB protein. This analysis is now being pursued in two directions. One involves the mapping of the antigenic sites on the LamB polypeptide. In this respect the site recognized by E-mAbs 177 and 302 has been shown to be located in the vicinity of the COOHterminal end of the polypeptide (7) . The other direction is the characterization of additional antigenic determinants. The results of competition experiments performed with Fab fragments and complete sera, both preadsorbed with whole cells and not preadsorbed (Fig. 2) , indicate that there are determinants which do not overlap those described here.
